BlackRock’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

BlackRock’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,480,897	Closed	-$161M	–	5837
2022 Q4	$161M	Buy	4,480,897 +218,820	+5%	+$5.47M	0.01%	1689
2022 Q3	$64.1M	Buy	4,262,077 +196,000	+5%	+$3.18M	﹤0.01%	2271
2022 Q2	$54.4M	Buy	4,066,077 +775,183	+24%	+$12.3M	﹤0.01%	2426
2022 Q1	$63.4M	Buy	3,290,894 +1,954,112	+146%	+$40.5M	﹤0.01%	2441
2021 Q4	$31.7M	Buy	1,336,782 +212,289	+19%	+$4.92M	﹤0.01%	2987
2021 Q3	$22.5M	Buy	+1,124,493	New	+$24.1M	﹤0.01%	3201

BlackRock's IMGO Position: Q1 2023 in Review

BlackRock sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 4,480,897 shares — an estimated $161M sold.

BlackRock first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $161M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

BlackRock reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
BlackRock sold 4,480,897 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $161M.
BlackRock first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
BlackRock's Imago BioSciences, Inc. Common stock position peaked at $161M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on BlackRock's 13F filing for Q1 2023, filed 12 May 2023.